Snapshot from Jul 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / National_Health_Service Atorvastatin...
Regulatory medical guidance

National_Health_Service Atorvastatin Side Effects Guidance

Analysis based on 15 articles · First reported Jun 25, 2026 · Last updated Jul 08, 2026

Sentiment
0
Attention
2
Articles
15
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The United Kingdom — National Health Service's guidance on Atorvastatin is unlikely to have a significant direct market impact as it is a common medication and the advice is a reiteration of known drug interactions and side effects. However, it serves as a reminder for pharmaceutical companies to ensure clear communication regarding medication safety.

Pharmaceuticals Healthcare
Event Summary

The United Kingdom — National Health Service has issued guidance to patients taking Atorvastatin, a widely used statin for lowering cholesterol, regarding potential serious side effects and interactions with other medications. The guidance advises patients to inform their doctor or pharmacist if they are taking certain antibiotics, antifungals, HIV medicines, hepatitis C medicines, Warfarin, Ciclosporin, Colchicine, contraceptive pills, Verapamil, Diltiazem, Amlodipine, Amiodarone, or considering Hypericum perforatum or Coenzyme Q10 supplements. The United Kingdom — National Health Service also detailed common and serious side effects, urging patients to seek medical attention for symptoms like unexplained muscle pain, yellowing skin/eyes, severe stomach pain, or lung disease symptoms.

Key Actions
65 United Kingdom — National Health Service advised
60 The Lancet Digital Health published research
Entities Involved
govactor
United Kingdom — National Health Service
The United Kingdom — National Health Service issued guidance on the safe use of atorvastatin, highlighting potential serious side effects and drug interactions.
Importance 100.0 Sentiment 0.0
oth
Ciclosporin
Ciclosporin is a medicine for psoriasis and rheumatoid arthritis, and its interaction with Atorvastatin is highlighted as a caution.
Importance 30.0 Sentiment 0.0
oth
Colchicine
Colchicine is a medicine for gout, and its interaction with Atorvastatin is highlighted as a caution.
Importance 30.0 Sentiment 0.0
oth
Verapamil
Verapamil is a medicine for high blood pressure and heart problems, and its interaction with Atorvastatin is highlighted as a caution.
Importance 30.0 Sentiment 0.0
oth
Diltiazem
Diltiazem is a medicine for high blood pressure and heart problems, and its interaction with Atorvastatin is highlighted as a caution.
Importance 30.0 Sentiment 0.0
oth
Amiodarone
Amiodarone is a medicine that helps if you have an irregular heartbeat, and its interaction with Atorvastatin is highlighted as a caution.
Importance 30.0 Sentiment 0.0
oth
Coenzyme Q10
Coenzyme Q10 is a supplement that patients are advised to consult their doctor or pharmacist about before taking with Atorvastatin.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.